Oncology Drug Shortages Persist

Abstract

Drug shortages in oncology have been an ongoing issue in the United States, leaving clinicians scrambling to ensure that patients have access to therapies. Depleted drug supplies have been particularly acute in pediatric oncology, and a recent shortage of vincristine demonstrates how shortages occur and how treatment centers respond—and highlights the need for better strategies to avoid or mitigate such situations.